Impact of pulmonary hypertension on mortality after operation for isolated aortic valve stenosis

Background: Pulmonary hypertension (PH) is a well-known independent risk factor for mortality and morbidity after cardiac surgery. However, no weight is given to PH in the current guidelines for the management of patients with aortic stenosis (AS) undergoing aortic valve replacement (AVR). The aim of our study was to evaluate the impact of preoperative PH on early and five-year survival in patients with severe AS undergoing isolated AVR. Methods: From January 2005 to July 2010, 422 consecutive patients with severe AS underwent isolated AVR. According to systolic pulmonary artery pressure (sPAP), PH was classified as none (sPAPS < 35 mmHg, N - 224), mild-moderate (35 <= sPAP < 50 mmHg, N - 159) and severe (sPAP >= 50 mmHg, N - 39). Results: Overall in-hospital mortality was 2.8%. Unadjusted mortality was 0.9%, 3.8% and 10.2% for patients with normal, mild-moderate and severe PH (p = 0.003). In multivariable analysis, severe PH (OR 4.1, 95 CI 1.1-15.3, p = 0.04) and New York Heart Association class III-IV (OR 14.9, 95% CI 1.8-117.8, p = 0.01) were independent risk factors of in-hospital mortality. Multivariable predictors of five-year survival were extracardiac arteriopathy (HR 2.8, 95%CI 1.6-4.9, p < 0.0001), severe PH (HR 2.4, 95% CI 1.2-4.6 p = 0.01), NHYA III-IV class (HR 2.3, 95%CI 1.3-4, p = 0.003), preoperative serum creatinine (HR 2.2, 95%CI, 1.6-3.1, p < 0.0001) and age (HR 1.08, 95%CI 1.03 - 1.13, p = 0.01). Five-year survival was 86% +/- 3% with normal sPAP, 81% +/- 4% with mild-moderate PH and 63 +/- 10% with severe PH (p < 0.001). Conclusions: In patients undergoing isolated AVR with severe AS, severe PH is an independent predictor of in-hospital mortality and five-year survival (C) 2013 Elsevier Ireland Ltd. All rights reserved.